Corey Miller

Dr. Corey Miller is a UCFS-trained MD/PhD with over a decade of experience as a T cell biologist, specializing in thymus function, T cell development, and T cell-mediated immunity, particularly in stromal-immune crosstalk.

His expertise includes project design, team management, and new venture creation. Dr. Miller excels in early, small, and collaborative team settings, showcasing creativity and proactive leadership.

In his academic pursuits, he has focused on unraveling the mechanisms behind the generation of a diverse and functional peripheral T cell pool from the thymus. As the CEO of Tendel Therapies, Dr. Miller spearheads the development of novel memory-promoting vaccines for treating HIV, infectious diseases, and cancer.

Dr. Corey Miller holds an impressive educational background, including a Doctor of Medicine (M.D.) and a Doctor of Philosophy (Ph.D.) in HIV Immunology & Stromal-Immune Interactions from UCFS, a Bachelor of Science (B.S.) in Biochemistry with Highest Honors from the University of Michigan, and a Visiting Scholar stint in Biochemistry at the University of Oxford.

Throughout his career, Dr. Miller has engaged in roles such as Postdoctoral Scholar at the Anderson Lab in UCSF and participation in the Medical Scientist Training Program (MD/PhD) at UCFS.